ChinaSpecialistCareSpecialtiesCare optionsRecordsSourcesFree Initial Review
Menu
Home / Cardiovascular Medicine / Mitral TEER
Cardiovascular medicine guide · 经导管二尖瓣缘对缘修复术

Mitral TEER in China

Considering mitral TEER in China? Start with valve imaging, eligibility and device-related scope. This guide helps you identify the relevant records, questions for the receiving team and the scope of an individual estimate before a visit is agreed.

Check my case & budgetRecords & cost enquiry ↓
Chinese structural heart specialist explaining mitral TEER to an international patient

Medical records & cost enquiry

Mitral TEER: assessment and cost questions

For Mitral TEER, the budget depends on the proposed care and the hospital. A useful estimate needs to distinguish:

  • Eligibility testing and valve anatomy review
  • The proposed device and procedural scope
  • Admission and follow-up imaging

Hospital medical fees, travel and our coordination services are separate. Any paid specialist review or coordination service is explained and agreed before you proceed.

Your next step

Start with your question

Tell us your diagnosis and what you need. Our free initial review checks the information and helps identify a suitable next step; it is not a specialist opinion or a hospital quotation.

Request a case-based estimate

Not ready to send records? Ask us first. Where hospital review is appropriate, we can help request an estimate. No travel commitment or mandatory proxy consultation.

Planning mitral TEER in ChinaHospital review · individual costs · visit and follow-up

Plan the visit around valve imaging, eligibility and device-related scope. Agree the assessment route before travel.

Records for the mitral TEER review

Tell us what you already have: Transthoracic echo with quantitative MR; Transesophageal echo images; Cardiac MRI if performed. Start with a short summary; after first contact we explain which records the receiving team needs and how to share them.

Confirm the proposed scope and costs

Before asking for a personal estimate, clarify: Eligibility testing and valve anatomy review; The proposed device and procedural scope; Admission and follow-up imaging. The receiving team confirms the proposed scope and hospital charges; coordination is agreed separately.

Visits and care after returning home

Ask how the heart team assesses suitability, the proposed device and continuing valve and heart-failure care. Tell us if you need interpretation or English-language documents, and confirm the relevant arrangements with the receiving team.

TEER reduces mitral leakage without open-heart surgery

A catheter-based device grasps portions of the mitral leaflets to improve their meeting point and reduce regurgitation. The procedure is guided by transesophageal echocardiography.

Primary degenerative and secondary functional regurgitation have different selection pathways. Anatomy, symptoms, ventricular size and function, pulmonary pressure and surgical risk must be assessed together.

Optimize the underlying disease first

For functional mitral regurgitation, guideline-directed heart-failure and rhythm treatment should be reviewed before TEER benefit is estimated.

Who may be considered?

Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about transcatheter edge-to-edge mitral repair.

  • Severe symptomatic primary regurgitation with high surgical risk and suitable anatomy.
  • Selected secondary regurgitation despite optimized heart-failure therapy.
  • A patient requiring multidisciplinary comparison of TEER and surgery.
  • Persistent symptoms where regurgitation is a major, treatable contributor.

What the specialist team must confirm

The structural heart team reviews transthoracic and transesophageal echo, leaflet anatomy, jet location, valve area and gradient, ventricular dimensions and function, pulmonary pressure, coronary disease, heart-failure treatment and surgical risk.

Key points for this treatment

Targetmitral regurgitation
Methodcatheter leaflet approximation
ImagingTEE-guided planning
DecisionTEER, surgery or medical care
Chinese imaging cardiologist and interventional team planning mitral leaflet repair with transesophageal echocardiography
Leaflet anatomy determines grasping feasibilityJet location, leaflet length, calcification and baseline valve area affect whether leakage can be reduced without creating stenosis.

From mechanism-based assessment to image-guided repair

TEER is used when the expected symptom or outcome benefit justifies residual leakage and procedural risk.

ClassifyDefine primary or secondary regurgitation
OptimizeTreat heart failure rhythm and ischemia
ScreenConfirm leaflet and chamber suitability
RepairPlace device and verify result

Follow both the valve result and the heart-failure pathway

Early echo evaluates residual regurgitation, valve gradient and pericardial or vascular complications.

Later care continues heart-failure treatment, rhythm and volume management, symptom review and interval echocardiography.

International patient attending echocardiography and heart failure follow-up after mitral TEER
A device does not replace medical therapyFunctional regurgitation can change as ventricular disease changes, so underlying treatment continues.
Leak reducedTrack symptoms and ventricular response
Residual MRDefine grade and clinical significance
High gradientMonitor for functional mitral stenosis
Not suitableReconsider surgery or medical care

Risks, limits and realistic expectations

Risks include bleeding, vascular injury, stroke, cardiac perforation, device detachment, residual regurgitation, mitral stenosis, emergency surgery and death. TEER may reduce but not eliminate leakage.

Do not delay urgent local care

New severe breathlessness, chest pain, fainting, stroke symptoms or rapidly worsening swelling needs urgent local care.

Before hospital review

Records for mitral TEER assessment

A safe international review depends on dated source reports, original imaging and a complete treatment timeline—not a diagnosis label alone.

Transthoracic echo with quantitative MR
Transesophageal echo images
Cardiac MRI if performed
Heart-failure treatment history
Coronary and rhythm assessment
Previous valve intervention reports
Kidney function and bleeding history
Functional status and hospitalization timeline
Continue reading

Related patient guides

Related guide

Coronary Angiography and PCI

Explore the assessment and planning questions for this related care pathway.

Related guide

TAVR / TAVI

Explore the assessment and planning questions for this related care pathway.

Related guide

Cardiovascular Medicine

Explore the assessment and planning questions for this related care pathway.

Tell us what you need

Ask about your care,
your hospital and your budget.

You can ask about suitability, an expert opinion, an appointment or the likely medical cost. If you are unsure, choose “Not sure — please advise”.

This enquiry is aboutMitral TEERNot sure — please advise

How a personal estimate is prepared

  1. Tell us about your case.Describe your diagnosis, main question and preferred city, if any.
  2. Share the relevant records.We explain what is needed and how to send it by WhatsApp or email.
  3. Request a hospital estimate.Where appropriate, we help request hospital review and a cost estimate. Any paid review is agreed first.

This is an enquiry, not an order or payment. Proxy consultation is not mandatory. Any service scope is agreed separately before you proceed.

Ask about Mitral TEER

A first enquiry is free. Email and permission to respond are required; the other details are optional. Any paid clinical review or coordination is discussed separately.

Included automatically so we know which procedure you are asking about.
A preference, not a confirmed appointment.
Please do not send passport numbers, card details or full medical files in this first enquiry. We will explain which records are needed next.

Send a short summary first. This is an enquiry, not an order, payment or confirmed appointment.

No booking or payment is made by sending this enquiry.
Editorial transparency

Medical sources

Patient information is based on established government and professional guidance. Content updated 5 October 2026. This is patient information, not an individual clinical assessment.